Why the study?
Little is reported in the literature regarding the management of catecholaminergic polymorphic ventricular tachycardia in pregnancy and during labor.
Case Report (n=1)
No
Successful management of CPVT during pregnancy and labor is achievable with a multidisciplinary approach and appropriate medical therapy.
INTRODUCTION: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic disorder that can cause fatal tachyarrhythmias brought on by physical or emotional stress. There is little reported in the literature regarding management of CPVT in pregnancy much less during labor. CASE PRESENTATION: A gravida 2, para 1 presented to our high-risk clinic at 15 weeks gestation with known CPVT. The Caucasian female patient had been diagnosed after experiencing a cardiac arrest following a motor vehicle accident and found to have a pathogenic cardiac ryanodine receptor mutation. An implantable cardioverter defibrillator was placed at that time. Her pregnancy was uncomplicated, and she was medically managed with metoprolol, flecainide, and verapamil. Her labor course and successful vaginal delivery were uncomplicated and involved a multidisciplinary team comprising specialists in electrophysiology, maternal fetal medicine, anesthesiology, general obstetrics, lactation, and neonatology. CONCLUSIONS: CPVT is likely underdiagnosed and, given that cardiovascular disease is a leading cause of death in pregnancy, it is important to bring further awareness to the diagnosis and management of this inherited arrhythmia syndrome in pregnancy.
No takes yet. Share an insight, caveat, or question.
Schumer et al. (2020) conducted a case report in Catecholaminergic polymorphic ventricular tachycardia (CPVT) in pregnancy (n=1). Multidisciplinary management (beta-blockers, flecainide, verapamil, ICD monitoring) was evaluated on Maternal and fetal outcomes during pregnancy and labor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: